Health Condition 1: H25-H28- Disorders of lens
Conditions
Interventions
Intervention1: Group A: Group A - will receive intranasal dexmedetomidine in doses of 2.5 µg/kg through mucosal atomised device in both the nostrils (single administration) about 30 minutes prior
Sponsors
Ankur Luthra
Eligibility
Inclusion criteria
Inclusion criteria: All ASA I and II children aged 1 to 8 years scheduled for cataract surgery under general anaesthesia
Exclusion criteria
Exclusion criteria: Children with cardiac anomalies, upper respiratory tract infection, liver disease, seizures or an acute medical condition, increased intracranial pressure, or a history of dexmedetomidine allergy will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of effectiveness of atomised vs nebulised dexmedetomidine as pre-medication in children undergoing cataract surgery in terms of parental separation score Emotional State Scale-4.Timepoint: 30 min after intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| To Compare 1. Mean time of onset of adequate sedation score 2. Success rate of IV cannulation 3. Parental separation 4. Mask acceptance 5. Haemodynamic changes 6. Wake up behaviour Timepoint: 30 min after intervention | — |
Countries
India
Contacts
Public ContactAnkur Luthra
Post Graduate Institute of Medical Education and Research, Chandigarh
Outcome results
None listed